Treatment
Treatment clinical trials
We’re tracking 8,571 recruiting studies that include Treatment, each written for real people, not researchers, below.
Recruiting studies
- NCT05004233Recruiting
Antiplatelet treatment imaging test for stroke patients
This study uses special microscope imaging (transmission electron microscopy) to look at tiny changes in platelets before and after starting an antiplatelet medicine. It’s testing whether platelets show clear structural signs around the start of treatment for a specific type of stroke.
Saint-EtienneAges 18 years+ - NCT05009394Recruiting
Surgery options for long-term pain after limb amputation
This trial studies different surgical approaches to reduce persistent pain in the leftover part of an amputated limb. You may be able to join if your post-amputation pain has lasted more than a year and your pain level stays high despite stable pain treatments and prosthesis use.
Chicago, IllinoisAges 18 years+ - NCT05009927RecruitingPhase 2
Check whether continuing imatinib works after long GIST control
This trial studies people with advanced or metastatic gastrointestinal stromal tumor (GIST) who have been on the drug imatinib for 10 years with stable, non-growing disease. The goal is to see how effective it is to keep imatinib going after this long period.
BesançonAges 18 years+ - NCT05023005Recruiting
Strain-Counterstrain therapy for piriformis muscle pain
This trial tests a hands-on physical therapy technique called “strain-counterstrain” to reduce pain from the piriformis muscle. It may help people whose pain is coming from that specific muscle rather than the low back.
Loma Linda, CaliforniaAges 18–65 - NCT05034835Recruiting
Compression garments for arm nerve pain in CRPS
This study tests whether wearing a special compression sleeve or garment can reduce pain in people with complex regional pain syndrome (CRPS) affecting the arm. It’s looking at pain changes while making sure it’s safe for your skin and blood flow.
Ploemeur, Brittany RegionAges 18 years+ - NCT05041907RecruitingPhase 2
Testing an antiviral’s effects in early COVID-19
This trial looks at how well an antiviral works in the body when started early in people with COVID-19 symptoms. You may be able to join if you’re an otherwise healthy adult with confirmed infection and symptoms for less than 4 days.
Minas GeraisAges 18–60 - NCT05061342Recruiting
Cancer or healthy volunteers share health and imaging survey data
This study collects information about how cancer care affects daily life, treatment side effects, and quality of life, and it stores imaging and related data for future research. You might be able to take part if you’re scheduled for treatment at the center (or you’re a healthy volunteer) and can complete the questionnaires.
Shenzhen, GuangdongAges 18 years+ - NCT05066178Recruiting
Speech therapy for children with autism who speak very little
This study tests a speech treatment plan for children on the autism spectrum who currently speak very little. It aims to improve speech clarity and ability to repeat sounds, but only if the child’s home language environment and participation needs fit the study rules.
Boston, MassachusettsAges 5–18 - NCT05089227RecruitingPhase 2
Long-term apixaban to prevent clots in autoimmune hemolytic anemia
This Phase 2 trial tests whether taking long-term apixaban (a blood thinner) can prevent venous blood clots in people with autoimmune hemolytic anemia (AIHA). It may help reduce the risk of dangerous clotting events if you meet safety and risk criteria.
DijonAges 18 years+ - NCT05146726Recruiting
Finding the best care for low blood before planned surgery
This study looks at how to detect and treat pre-surgery anemia (low hemoglobin/low blood level) in people having planned operations where blood transfusion is likely. Some participants may also use a machine that collects and returns their own blood during surgery to reduce the need for donor blood.
BerlinAges 18 years+ - NCT05169385Recruiting
Parent support for teens in residential treatment for substance misuse
This trial tests a parent-focused program (via interviews and texting) for families when a teen is leaving residential treatment. It aims to help parents/guardians support their teen after discharge and reduce substance-related risk.
Rockford, IllinoisAges 12–18 - NCT05189223Recruiting
Values coaching for veterans starting opioid addiction medicines
This study tests a brief “values-based” coaching/support session to help veterans adjust and stick with early treatment for opioid use disorder. It may help you feel more grounded and supported during the first months after starting medicines like buprenorphine, methadone, or naltrexone.
Bedford, MassachusettsAges 18 years+ - NCT05199909RecruitingPhase 2
Testing zanubrutinib for antiphospholipid syndrome with low platelets
This Phase 2 study tests zanubrutinib, a medicine for the immune system, to treat antiphospholipid syndrome when it causes very low platelet counts. It looks at safety and whether it can improve blood clotting problems and low platelets when prior steroid treatment didn’t work well.
Tianjin, Tianjin MunicipalityAges 18 years+ - NCT05214391RecruitingPhase 2
Zanubrutinib for chronic immune low platelets after prior treatments
This Phase 2 study looks at zanubrutinib, a new medication, in people with immune thrombocytopenia (ITP) whose low platelet count has lasted more than 3 months and has not responded to prior steroid and other treatments. It may help raise platelets and reduce bleeding risk when other therapies have not worked.
Tianjin, Tianjin MunicipalityAges 18 years+ - NCT05214612Recruiting
Predictors of outcomes in myasthenia gravis
This study looks at what helps predict outcomes in people with myasthenia gravis (MG). It may help doctors better forecast how MG will progress and which factors matter most for recovery and long-term health.
AsyutAges 16 years+ - NCT05221450Recruiting
Study of what affects root canal treatment outcomes
This study looks at which factors can change how well root canal (endodontic) treatment works. It may help improve future care by understanding what leads to better healing.
LjubljanaAges 18 years+ - NCT05242055Recruiting
Tracking and treating chronic kidney disease risk
This trial looks at how well an integrated program for identifying and treating people at risk for chronic kidney disease (CKD) can improve outcomes. It may help by catching problems earlier and guiding treatment sooner.
Beijing, Beijing MunicipalityAges 18–100 - NCT05247125RecruitingPhase 4
Testing light or melatonin to help brain recovery after stroke
This study looks at whether changing your sleep timing using light therapy or melatonin can improve “brain rewiring” after an ischemic stroke. It mainly focuses on people who arrive very soon after stroke symptoms and who also meet specific safety and sleep/medication requirements.
Saint PetersburgAges 18–80 - NCT05259605Recruiting
Study uses brain tumor tissue and scans to track treatment outcomes
This is an observational study that collects and compares information from patients with primary brain tumors and their treatment results. It uses stored tumor tissue and brain scans to better understand outcomes using updated tumor classification methods.
InnsbruckAges 18 years+ - NCT05283512Recruiting
IV versus drink fluids to protect kidneys after CT scan
This study compares giving fluids through a vein versus drinking fluids to lower the risk of sudden kidney injury after a CT scan with contrast dye. It focuses on adults with very poor kidney function who are scheduled for an elective CT scan.
Odense C, FynAges 18 years+ - NCT05289258Recruiting
Barlow-style program for thinking and memory problems after breast cancer
This trial tests a structured “Barlow Protocol” program to help improve mild to moderate thinking and memory problems in people who finished breast cancer chemotherapy. It may help if your cognitive symptoms started after treatment and you’re not already in similar therapy.
CórdobaAges 18–70 - NCT05292235Recruiting
Study of surgery outcomes for prostate enlargement
This study looks at how well surgery works for an enlarged prostate (“benign prostatic hyperplasia”) and which care factors affect results. It may help improve future treatment planning and outcomes for people in Hong Kong.
Hong KongAges 18 years+ - NCT05326204Recruiting
Compare one vs two hours of blood sugar checks
This trial tests whether checking your blood sugar one hour after meals works just as well as checking two hours after meals for people with gestational diabetes who are already on treatment. It may help simplify monitoring and improve how safely diabetes is managed during pregnancy.
Kuala Lumpur, W.PersekutuanAges 18–45 - NCT05326477Recruiting
Study factors that predict how well behavioral weight plans work
This study looks at which personal and health factors help or hurt how well behavioral obesity treatments work. It may help doctors better tailor weight-treatment plans for people with obesity.
Chicago, IllinoisAges 18 years+
Common questions
- Are there clinical trials studying Treatment?
- Yes. Clin2 currently lists 8,571 recruiting studies that include Treatment, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Treatment trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Treatment an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Treatment or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.